Related references
Note: Only part of the references are listed.US Renal Data System 2017 Annual Data Report Epidemiology of Kidney Disease in the United States
Rajiv Saran et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Slit2/Robo1 signaling is involved in angiogenesis of glomerular endothelial cells exposed to a diabetic-like environment
Junhui Liu et al.
ANGIOGENESIS (2018)
Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis
Lei Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/-Catenin Pathways
Zhi-Yu Song et al.
CANCER INVESTIGATION (2018)
Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability
Xiaoyan Zhou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway
Jiting Yan et al.
PHARMACOLOGICAL RESEARCH (2018)
The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells
Jialing Rao et al.
SCIENTIFIC REPORTS (2017)
Advanced glycation end products promote VEGF expression and thus choroidal neovascularization via Cyr61-PI3K/AKT signaling pathway
Lijuan Sun et al.
SCIENTIFIC REPORTS (2017)
Catalpol preserves neural function and attenuates the pathology of Alzheimer's disease in mice
Jin-Zhong Huang et al.
MOLECULAR MEDICINE REPORTS (2016)
MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways
Ranran Tang et al.
CANCER LETTERS (2016)
Vascular nitric oxide: Beyond eNOS
Yingzi Zhao et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Advanced glycation end products induce glomerular endothelial cell hyperpermeability by upregulating matrix metalloproteinase activity
Pengli Luo et al.
MOLECULAR MEDICINE REPORTS (2015)
The glycocalyx-linking albuminuria with renal and cardiovascular disease
Ton J. Rabelink et al.
NATURE REVIEWS NEPHROLOGY (2015)
Role of Src in Vascular Hyperpermeability Induced by Advanced Glycation End Products
Weijin Zhang et al.
SCIENTIFIC REPORTS (2015)
High-fat diet induces endothelial dysfunction through a down-regulation of the endothelial AMPK-PI3K-Akt-eNOS pathway
Concha F. Garcia-Prieto et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
Nitric oxide system and diabetic nephropathy
Bruno Schmidt Dellamea et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Zinc regulates iNOS-derived nitric oxide formation in endothelial cells
Miriam M. Cortese-Krott et al.
REDOX BIOLOGY (2014)
Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells
Hee-Jung Choi et al.
FITOTERAPIA (2013)
Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-κB pathway activation in human umbilical vein endothelial cells
Liang Feng et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells
Hong Li et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Current Therapeutic Strategies to Mitigate the eNOS Dysfunction in Ischaemic Stroke
Kirtiman Srivastava et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Nitric oxide synthases: regulation and function
Ulrich Foerstermann et al.
EUROPEAN HEART JOURNAL (2012)
Inhibition of Insulin Signaling in Endothelial Cells by Protein Kinase C-induced Phosphorylation of p85 Subunit of Phosphatidylinositol 3-Kinase (PI3K)
Yasuhiro Maeno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The glomerular endothelium emerges as a key player in diabetic nephropathy
Simon C. Satchell
KIDNEY INTERNATIONAL (2012)
Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy
E. Jennifer Weil et al.
KIDNEY INTERNATIONAL (2012)
Differential modulation of angiogenesis by advanced glycation end products
Manju S. Devi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Functional Significance of Cytosolic Endothelial Nitric-oxide Synthase (eNOS) REGULATION OF HYPERPERMEABILITY
Fabiola A. Sanchez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
RAGE: a single receptor fits multiple ligands
Guenter Fritz
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Nitric Oxide Synthesis Is Reduced in Subjects With Type 2 Diabetes and Nephropathy
Paolo Tessari et al.
DIABETES (2010)
Blockade of PKC-beta protects HUVEC from advanced glycation end products induced inflammation
Youhua Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase
Aino Soro-Paavonen et al.
JOURNAL OF HYPERTENSION (2010)
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy
Sally A. Penfold et al.
KIDNEY INTERNATIONAL (2010)
RAGE, glomeruloscierosis and proteinuria: Roles in podocytes and endothelial cells
Vivette DAgati et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products
Chun Liang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response
Shi Fang Yan et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
The Pathologic Continuum of Diabetic Vascular Disease
Gabriela Orasanu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease
Fangfang Peng et al.
DIABETES (2008)
Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy
Bernd Hohenstein et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
ADVANCED GLYCATION END PRODUCTS IN RENAL FAILURE: AN OVERVIEW
M. J. Noordzij et al.
JOURNAL OF RENAL CARE (2008)
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy
G. H. Tesch
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production
Sharma Prabhakar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Suppression of complement regulatory protein C1 inhibitor in vascular endothelial activation by inhibiting vascular cell adhesion molecule-1 action
Haimou Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy
Takahiko Nakagawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Macrophage accumulation in human progressive diabetic nephropathy
Duy Nguyen et al.
NEPHROLOGY (2006)
Depression of progenitor cell function by advanced glycation endproducts (AGEs): Potential relevance for impaired angiogenesis in advanced age and diabetes
Robert J. Scheubel et al.
EXPERIMENTAL GERONTOLOGY (2006)
2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice
K Ichinose et al.
DIABETES (2006)
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man
B Hohenstein et al.
KIDNEY INTERNATIONAL (2006)
Leukocyte recruitment and vascular injury in diabetic nephropathy
Elena Galkina et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation
L Pala et al.
MICROVASCULAR RESEARCH (2005)
Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model
K Ichinose et al.
DIABETES (2005)
Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity
D Predescu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice
FY Chow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptors
T Ostendorf et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Regulation of the expression of inducible nitric oxide synthase
H Kleinert et al.
BIOLOGICAL CHEMISTRY (2003)
Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury
ZM Zhou et al.
CIRCULATION (2003)
Advanced glycosylation end products induce NF-κB dependent NOS expression in RAW 264.7 cells
CH Wu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Share Paper
